Vastech Vein Care Center Manhasset, NY - 11030

Vastech Vein Care Center is categorized under Surgeons in Manhasset, NY and active since 1989.

Vastech Vein Care Center was established in 1989, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Louise Attkiss, Office Manager at the company’s single location by writing to 1165 Northern Boulevard # 402, Manhasset, New York NY 11030 or by phoning (516) 869-1500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vastech Vein Care Center
Contact Person: Louise Attkiss, Office Manager
Address: 1165 Northern Boulevard # 402, Manhasset, New York 11030
Phone Number: (516) 869-1500
Website Address: michaeljattkissmd.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1989
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Surgeons
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Vastech Vein Care Center was started in 1989 to provide professional Surgeons under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Louise Attkiss, Office Manager for inquiries that concern Vastech Vein Care Center by calling the company number (516) 869-1500, as your correspondence is most welcome. Additionally, the physical location of the single location of Vastech Vein Care Center can be found at the coordinates 40.79082,-73.70266 as well as the street address 1165 Northern Boulevard # 402 in Manhasset, New York 11030.

For its online presence, you may visit Vastech Vein Care Center’s website at michaeljattkissmd.com and engage with its social media outlets through on Twitter and on Facebook.